Search Results 1881-1890 of 16689 for mesenteric fat and ibd

1. S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery - Mayo Clinic

   About this study. RATIONALE: Everolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth or by blocking blood flow ...

2. A Study to Evaluate the Use of Nivolumab and Pomalidomide Combination for Relapsed/Refractory Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma - Mayo Clinic

   Pomalidomide may stimulate the immune system to kill cancer cells. Drugs used in chemotherapy, such as dexamethasone, work in different ways to stop the growth ...

3. A Study of the Effectiveness and Safety of Pembrolizumab (MK-3475) for Women with Advanced Recurrent Ovarian Cancer - Mayo Clinic

   Brain tumor, breast cancer, colon cancer, congenital heart disease, heart arrhythmia. ... Has symptoms of bowel obstruction in the past 3 months; Has known ...

4. Weight loss recipes - Mayo Clinic

   Weight loss recipes from the nutrition experts at Mayo Clinic ... Low-fat turkey gravy · Mango salsa · Orange basil vinaigrette · Peach honey spread ...

5. Carotid endarterectomy - Doctors & Departments - Mayo Clinic

   ... Mesenteric ischemia, Varicose vein, Deep vein thrombosis, Vascular malformation, Thoracic aortic aneurysm, Abdominal aortic aneurysm, Aortic dissection ...

6. Meningioma - Doctors and departments - Mayo Clinic

   ... Gastrointestinal stromal tumor, Small bowel cancer, Ampullary cancer, Lung cancer, Neurofibroma, Spine tumor, Brain cancer, Choroid plexus papilloma. Show ...

7. Publications - Joseph H. Butterfield, M.D. - Mayo Clinic

   ... Ulcerative Colitis. Monoclon Antib Immunodiagn Immunother. 2016 Dec; 35 (6):300-303 Epub 2016 Dec 02. View PubMed; Chen LT, Chen CT, Jiaang WT, Chen TY ...

8. Mayo Clinic

   And in rare patients, it can increase the risk of certain rare malignancies, such as lymphoma or small bowel cancers. So this is not a trivial disease and it ...

9. Management of recurrent Clostridioides difficile infection and use of fecal microbiota transplantation during the COVID-19 pandemic - Mayo Clinic

   "About 20% of patients develop post-infectious irritable bowel syndrome, and there is also a high risk of persistently positive nucleic acid-based assay after ...

10. Safety and Efficacy of Polymyxin B Hemoperfusion (PMX) for Endotoxemic Septic Shock in a Randomized, Open-Label Study - Mayo Clinic

    The purpose of this study is to compare the safety and effectiveness of the PMX cartridge (Toraymyxin) based on mortality at 28 days in patients with septic ...